Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial strategies to target RAS-driven cancers
Naiara Perurena, Lisa Situ, Karen Cichowski
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 316-337
Closed Access | Times Cited: 22

Showing 22 citing articles:

Anticancer drugs: How to select small molecule combinations?
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 503-519
Closed Access | Times Cited: 13
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Marie‐Julie Nokin, Alessia Mira, Enrico Patrucco, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020
Yanqing Liu, Jie Chen, Xiang Li, et al.
Pharmacological Research (2025) Vol. 212, pp. 107577-107577
Open Access
Cycling Molecular Assemblies for Selective Cancer Cell Golgi Disruption
Weiyi Tan, Qiuxin Zhang, Zhiyu Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Visible Light-Triggered Single-Component Photocage Nanoparticles for Combinatorial Photodynamic Therapy and Chemotherapy
Souvik Ray, Pritam Roy, N. D. Pradeep Singh
ACS Applied Nano Materials (2025)
Closed Access
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
Reducing pERKs to Break “RAS”istance to Sotorasib
Steven G. Gray, Derbrenn O'Connor, Luciano Mutti, et al.
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 3, pp. 259-261
Closed Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
The Persistent Power of the Taxane/Platin Chemotherapy
Lucy B. Xu, Elizabeth R. Smith, Vasili Koutouratsas, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1208-1208
Open Access
Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery
Yutong Wang, Shiyu Luo, Hongbao Sun, et al.
Drug Discovery Today (2025), pp. 104347-104347
Closed Access
Targeting the Yin and Yang of KRASG12C
Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Trends in Molecular Medicine (2025)
Closed Access
Histamine 1 Receptor (HRH1): A potential therapeutic target for Pancreatic Ductal Adenocarcinoma
Cristina Salmerón, Elena Tomás Bort, Krishna Bajee Sriram, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103573-103573
Closed Access
HRS-4642: The next piece of the puzzle to keep KRAS in check
Alejandra A. Flores-Gómez, Matthias Drosten
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1157-1159
Closed Access | Times Cited: 4
Finding the sweet spot: Targeting RAS in tumors while sparing normal tissue
Naiara Perurena, Karen Cichowski
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 943-945
Closed Access | Times Cited: 3
Resistance to KRAS inhibition in advanced non-small cell lung cancer
Katherina Bernadette Sreter, Maria Joana Catarata, Maximilian von Laffert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)
Yaxuan Sun, Xiaohui Hu
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 2
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer
Jeffrey H. Becker, Anastasia E. Metropulos, Christina Spaulding, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3629-3639
Open Access | Times Cited: 2
Exhaustive in vitro evaluation of the 9-drug cocktail CUSP9 for treatment of glioblastoma
Efthymia Chantzi, Ulf Hammerling, Mats G. Gustafsson
Computers in Biology and Medicine (2024) Vol. 178, pp. 108748-108748
Open Access | Times Cited: 1
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia
Maierbiya Abulimiti, Zheng-yi Jia, Yun Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 2797-2826
Closed Access | Times Cited: 1
Untangling sporadic brain arteriovenous malformations: towards targeting the KRAS/MAPK pathway
Rashad Jabarkheel, Lun Li, Maxwell Frankfurter, et al.
Frontiers in Surgery (2024) Vol. 11
Open Access | Times Cited: 1
Unraveling atomic-scale mechanisms of GDP extraction catalyzed by SOS1 in KRAS-G12 and KRAS-D12 oncogenes
Zheyao Hu, Jordi Martı́
Computers in Biology and Medicine (2024) Vol. 186, pp. 109599-109599
Open Access | Times Cited: 1
Right ON target: a new RAS-GTP inhibitor
Daniela Senft
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 361-361
Closed Access
Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development
Emmanuel Chamorey, Jocelyn Gal, Baharia Mograbi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 816-816
Open Access
Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial
Rafael Rosell, María González‐Cao, Miguel Ángel Molina‐Vila
The Lancet Respiratory Medicine (2024)
Closed Access
Bioactive potency of extracts from Stylissa carteri and Amphimedon chloros with silver nanoparticles against cancer cell lines and pathogenic bacteria
Moath Alqaraleh, Khaled M. Khleifat, Ali Al‐Samydai, et al.
Biomedical Reports (2024) Vol. 22, Iss. 2
Open Access
Page 1

Scroll to top